Principal Investigator

Stephen Dewhurst, Ph.D. University of Rochester work Box 672 601 Elmwood Ave Rochester NY 14642 office: MRBX 2-1110 p (585) 275-3216

Honors & News

2015 2014 2013 2012

  • April 30, 2015

    URMC Start-up Takes Aim at Memory and Cognitive Problems

    Medications are available to treat many of the symptoms of neurodegenerative diseases like multiple sclerosis and Parkinson's disease, but there is no drug or other therapy that improves the memory and cognitive problems that often plague patients. A new start-up company, built around research conducted at the University of Rochester School of Medicine and Dentistry, hopes to change that.

    Camber NeuroTherapeutics Inc., founded based on discoveries made in the laboratories of Harris “Handy” A. Gelbard, M.D., Ph.D.  and Stephen Dewhurst, Ph.D., plans to attack the cognitive component of neurodegenerative diseases using a completely new approach: stopping the inflammation in the brain, so-called neuroinflammation, that impairs the function of nerve cells and the vast networks they create. These neural networks allow us to store and recall memories, plan and prioritize, focus on particular tasks, and process sensory information.

Recent Publications